Beneficial Role of Bitter Melon Supplementation in Obesity and Related Complications in Metabolic Syndrome
Open accessThe DOI matches its Crossref record; 152 of the 153 references it cites were found in a registry or an index.
Abstract
Diabetes, obesity, and metabolic syndrome are becoming epidemic both in developed and developing countries in recent years. Complementary and alternative medicines have been used since ancient era for the treatment of diabetes and cardiovascular diseases. Bitter melon is widely used as vegetables in daily food in Bangladesh and several other countries in Asia. The fruits extract of bitter melon showed strong antioxidant and hypoglycemic activities in experimental condition both in vivo and in vitro. Recent scientific evaluation of this plant extracts also showed potential therapeutic benefit in diabetes and obesity related metabolic dysfunction in experimental animals and clinical studies. These beneficial effects are mediated probably by inducing lipid and fat metabolizing gene expression and increasing the function of AMPK and PPARs, and so forth. This review will thus focus on the recent findings on beneficial effect of Momordica charantia extracts on metabolic syndrome and discuss its potential mechanism of actions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Additionally, its anti-inflammatory and antioxidant properties may alleviate obesity-related inflammation, potentially amplifying the pro-insulinotropic and β-cell protective effects of GLP-1 [204,324,325].”
From Nutritional Approaches to Enhance GLP-1 Analogue Therapy in Obesity: A Narrative Review (2025) · cites this paper as [204]
Experimental — accuracy not yet measuredIn the citing paper
“Another trial in T2DM patients showed that 3 months of cinnamon (1 g/day) decreased fasting and postprandial glucose, HbA1c, fasting insulin, insulin resistance, body weight, BMI, body fat (including visceral fat), and improved cholesterol profiles, with greater benefits in overweight individuals (BMI ≥ 27) [204].”
From Nutritional Approaches to Enhance GLP-1 Analogue Therapy in Obesity: A Narrative Review (2025) · cites this paper as [204]
In the citing paper
“Another trial in T2DM patients showed that 3 months of cinnamon (1 g/day) decreased fasting and postprandial glucose, HbA1c, fasting insulin, insulin resistance, body weight, BMI, body fat (including visceral fat), and improved cholesterol profiles, with greater benefits in overweight individuals (BMI ≥ 27) [204].”
From Nutritional Approaches to Enhance GLP-1 Analogue Therapy in Obesity: A Narrative Review (2025) · cites this paper as [204]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pharmacological interventions for somatoform disorders in adults
Kleinstäuber, M., Witthöft, M., Steffanowski, A., van Marwijk, H., Hiller, W., & Lambert, M. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010628.pub2 · Cited by 11,335
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041 · cited 1×
“Furthermore, inflammatory cells such as macrophages infiltration are also increased in adipose tissues [12].”
BackgroundLagouge, M., Argmann, C., Gerhart-Hines, Z., Meziane, H., Lerin, C., Daussin, F., Messadeq, N., Milne, J., Lambert, P., Elliott, P., et al. (2006) · Cell · doi:10.1016/j.cell.2006.11.013 · Cited by 4,057
Finucane, M. M., Stevens, G. A., Cowan, M. J., Danaei, G., Lin, J. K., Paciorek, C. J., Singh, G. M., Gutierrez, H. R., Lu, Y., Bahalim, A. N., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62037-5 · Cited by 4,050
Guh, D. P., Zhang, W., Bansback, N., Amarsi, Z., Birmingham, C. L., & Anis, A. H. (2009) · BMC Public Health · doi:10.1186/1471-2458-9-88 · Cited by 3,855
Global burden of obesity in 2005 and projections to 2030
Kelly, T., Yang, W., Chen, C.-S., Reynolds, K., & He, J. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.102 · Cited by 3,319 · cited 1×
“It has been estimated that 58% of world population will become obese by 2030 [1].”
BackgroundKim, H. J., Park, S. Y., Choi, Y. J., Han, S. J., Lee, K. W., & Kim, D. J. (2013) · Hormone Research in Paediatrics · doi:10.1159/000348848 · Cited by 3,048
Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB
Cai, D., Yuan, M., Frantz, D. F., Melendez, P. A., Hansen, L., Lee, J., & Shoelson, S. E. (2005) · Nature Medicine · doi:10.1038/nm1166 · Cited by 2,245
Subcutaneous and visceral adipose tissue: Structural and functional differences
Ibrahim, M. M. (2010) · Obesity Reviews · doi:10.1111/j.1467-789x.2009.00623.x · Cited by 2,238 · cited 4×
“ACC: Acetyl-CoA carboxylase ACE: Angiotensin-converting enzyme ALP: Alkaline phosphatase AST: Aspartate transaminase ALT: Alanine aminotransferase AMPK: 5 AMP-activated protein kinase (5 adenosine monophosphate-activated protein kinase) ApoB: Apolipoprotein B BAT: Brown adipose tissue BMI: Body mass index C/EBP: CEBPB…”
BackgroundInfluentialPuigserver, P., & Spiegelman, B. M. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0012 · Cited by 2,076
Research works printed but not linked: 7
- M. R. Khan and A. D. Omoloso, "Momordica charantia and Allium sativum: broad spectrum antibacterial activity, " Korean Journal of Pharmacognosy, vol. 29, no. 3, pp. 155-158, 1998.
- F. Bano, N. Akthar, and H. Naz, "Effect of the aqueous extracts of Momordica charantia on body weight of rats, " Journal of Basic and Applied Sciences, vol. 7, pp. 1-5, 2011.
- K. Zahra, M. A. Malik, M. S. Mughal, M. Arshad, and M. I. Sohail, "Hepatoprotective role of extracts of Momordica charantia L. in acetaminophen-induced toxicity in rabbits, " Journal of Animal and Plant Sciences, vol. 22, no. 2, pp. 273-277, 2012.
- R. H. H. Ching, L. O. Y. Yeung, I. M. Y. Tse, W.-H. Sit, and E. T. S. Li, "Supplementation of bitter melon to rats fed a high-fructose diet during gestation and lactation ameliorates fructose-induced dyslipidemia and hepatic oxidative stress in male offspring, " The Journal of Nutrition, vol. 141, no. 9, pp. 1664-1672, 2011. · DOI
- Y. Oishi, T. Sakamoto, H. Udagawa et al., "Inhibition of increases in blood glucose and serum neutral fat by Momordica charantia saponin fraction, " Bioscience, Biotechnology and Biochemistry, vol. 71, no. 3, pp. 735-740, 2007. · DOI
- C.-H. Tsai, E. C.-F. Chen, H.-S. Tsay, and C.-J. Huang, "Wild bitter gourd improves metabolic syndrome: a preliminary dietary supplementation trial, " Nutrition Journal, vol. 11, article 4, 2012. · DOI · Paper page
- R. Horax, N. Hettiarachchy, and P. Chen, "Extraction, quan- tification, and antioxidant activities of phenolics from pericarp and seeds of bitter melons (Momordica charantia) harvested at three maturity stages (immature, mature, and ripe), " Journal of Agricultural and Food Chemistry, vol. 58, no. 7, pp. 4428-4433, 2010. · DOI · Paper page
Cited by
Therapeutic potential of ectopic olfactory and taste receptors
Lee, S.-J., Depoortere, I., & Hatt, H. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-018-0002-3 · Cited by 279
The Management of Diabetes Mellitus Using Medicinal Plants and Vitamins
Yedjou, C. G., Grigsby, J., Mbemi, A., Nelson, D., Mildort, B., Latinwo, L., & Tchounwou, P. B. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24109085 · Cited by 202
“It regulates and lowers blood glucose in diabetes patients by improving insulin sensitivity and reducing glucose production in the liver [36].”
BackgroundNattagh‐Eshtivani, E., Barghchi, H., Pahlavani, N., Barati, M., Amiri, Y., Fadel, A., Khosravi, M., Talebi, S., Arzhang, P., Ziaei, R., et al. (2022) · Phytotherapy Research · doi:10.1002/ptr.7312 · Cited by 180
Valenzuela, J., Manzano, S., Palma, F., Carvajal, F., Garrido, D., & Jamilena, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18071467 · Cited by 176
Momordica charantia, a Nutraceutical Approach for Inflammatory Related Diseases
Bortolotti, M., Mercatelli, D., & Polito, L. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00486 · Cited by 173
Bitter melon ( Momordica charantia ): a natural healthy vegetable
Saeed, F., Afzaal, M., Niaz, B., Arshad, M. U., Tufail, T., Hussain, M. B., & Javed, A. (2018) · International Journal of Food Properties · doi:10.1080/10942912.2018.1446023 · Cited by 179
“It might be beneficial to include bitter melon in our daily life.([123,124]) For keratinocytes, the protective action of the extract associated with oxidant”
BackgroundChan, D. W., Yung, M. M. H., Chan, Y.-S., Yang, X., Yang, H., Xu, D., Zhan, J., Chan, K. K. L., Ng, T., & Ngan, H. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105157 · Cited by 131
Venkatakrishnan, K., Chiu, H., & Wang, C. (2019) · Food & Function · doi:10.1039/c9fo00293f · Cited by 85
Sagor, A. T., Chowdhury, M. R. H., Tabassum, N., Hossain, H., Rahman, M., & Alam, M. A. (2015) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-015-0636-1 · Cited by 58
“Moreover, cucurbitane type triterpenoids such as charantin, kuguacins, momordicin, and karavilagenins were also isolated from Momordica charantia [18].”
BackgroundSelf-citationSur, S., Steele, R., Aurora, R., Varvares, M. A., Schwetye, K. E., & Ray, R. B. (2018) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-17-0237 · Cited by 69
“Different in vitro and in vivo studies also reported a potential beneficial effect of bitter melon against lipid and glucose metabolic dysfunction (34).”
BackgroundWang, L., Wei, Y., Ning, C., Zhang, M., Fan, P., Lei, D., Du, J., Gale, M., Ma, Y.-T., & Yang, Y. (2019) · Endocrine Journal · doi:10.1507/endocrj.ej18-0467 · Cited by 53
Pahlavani, N., Roudi, F., Zakerian, M., Ferns, G. A., Navashenaq, J. G., Mashkouri, A., Ghayour‐Mobarhan, M., & Rahimi, H. R. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28483 · Cited by 52
“charantia can be divided into several groups: flavonoid, and phenolic compounds, cucurbitane type triterpenoids, oleanane‐type triterpene, cucurbitane‐type triterpene glycoside, insulin‐like peptides, and saponins.(23) The phenolic compounds include caffeic acid, coumaric acid, ferulic acid, and gallic acid.”
BackgroundThiagarajan, S. K., Krishnan, K. R., Ei, T., et al. (2019) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2019/9152757 · Cited by 45
“This influences the heart rate causing the heartbeat to slow down [38].”
BackgroundPhytochemical profile and biological activities of Momordica charantia L. (Cucurbitaceae): A review
Mozaniel, S. D. O., Wanessa, A. D. C., Fernanda, W. F. B., Araújo, M. E., Gracialda, C. F., & Raul, N. D. C. J. (2018) · AFRICAN JOURNAL OF BIOTECHNOLOGY · doi:10.5897/ajb2017.16374 · Cited by 52
Sun, L., Zhang, X., Dong, L. F., Zhang, C., Guo, P., & Wu, C. (2020) · Journal of Food Composition and Analysis · doi:10.1016/j.jfca.2020.103726 · Cited by 44
Shim, S. H., Sur, S., Steele, R., Albert, C. J., Huang, C., Ford, D. A., & Ray, R. B. (2018) · Molecular Carcinogenesis · doi:10.1002/mc.22882 · Cited by 42
“Potential beneficial effect of bitter melon against lipid and glucose metabolic dysfunction has been reported.(17) In this study, we have investigated the role of BME on lipid metabolism in TNBC cell lines.”
BackgroundNatural products for managing metabolic syndrome: a scoping review
Abdulghani, M. F., & AL‐Fayyadh, S. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1366946 · Cited by 45
Insulin resistance induced by obesity: Mechanisms, metabolic implications and therapeutic approaches
Choo, Y. N., Ravi, R. N., & Subramaniyan, V. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-11509-3 · Cited by 55
“A study found that exercising 5 days per week, with each session lasting 45 min and including an aerobic and a strength period, significantly reduces fast - ing and postprandial blood glucose levels [78].”
Nerurkar, P. V., Orias, D., Soares, N., Kumar, M., & Nerurkar, V. R. (2019) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2019.03.003 · Cited by 35
Jandari, S., Ghavami, A., Ziaei, R., Nattagh‐Eshtivani, E., Kelishadi, M. R., Sharifi, S., Khorvash, F., Pahlavani, N., & Mohammadi, H. (2020) · International Journal of Food Properties · doi:10.1080/10942912.2020.1833916 · Cited by 37
Apoptosis and Anti-cancer Drug Discovery: The Power of Medicinal Fungi and Plants
Wong, J. H., Sze, S. C. W., Ng, T. B., Cheung, R. C. F., Tam, C., Zhang, K. Y., Dan, X., Chan, Y. S., Cho, W. C. S., Ng, C. C. W., et al. (2017) · Current Medicinal Chemistry · doi:10.2174/0929867324666170720165005 · Cited by 29
TRADITIONAL MEDICINAL SYSTEMS FOR TREATMENT OF DIABETES MELLITUS: A REVIEW
Dimple, D., Kumar, A., Kumar, V., & Tomer, V. (2018) · International Journal of Pharmacy and Pharmaceutical Sciences · doi:10.22159/ijpps.2018v10i5.25374 · Cited by 36
“The beneficial effect of bitter melon has been reported due to its ability to maintain the structural integrity of the pancreatic islets and regulating the synthesis and release of pancreatic hormones [19].”
BackgroundAlam, P., Raka, M. A., Khan, S., Sarker, J., Ahmed, N., Nath, P. D., Hasan, N., Mohib, M. M., Tisha, A., & Sagor, M. A. T. (2018) · Journal of Herbal Medicine · doi:10.1016/j.hermed.2018.09.006 · Cited by 33
Alotaibi, G., & Alkhammash, A. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177509 · Cited by 32
Yalçın, E., & Çavuşoğlu, K. (2022) · Scientific Reports · doi:10.1038/s41598-022-24692-7 · Cited by 25
Wasabi supplementation alters the composition of the gut microbiota of diet-induced obese rats
Thomaz, F. S., Tomsett, K. I., Panchal, S. K., Worrall, S., & Nitert, M. D. (2020) · Journal of Functional Foods · doi:10.1016/j.jff.2020.103868 · Cited by 24
Momordica charantia reverses type II diabetes in rat
Malekshahi, H., Bahrami, G., Miraghaee, S., Ahmadi, S. A., Sajadimajd, S., Hatami, R., Mohammadi, B., & Keshavarzi, S. (2019) · Journal of Food Biochemistry · doi:10.1111/jfbc.13021 · Cited by 23
Cui, Y., Wu, H., Li, Q., JianWen, L., Gao, P., Sun, F., Zhang, H., Lu, Z., Wei, X., He, C., et al. (2019) · Hypertension · doi:10.1161/hypertensionaha.119.13358 · Cited by 23
Gong, Z., Zhang, J., & Xu, Y. (2016) · Phytotherapy Research · doi:10.1002/ptr.5748 · Cited by 30
“charantia may modulate fat metabolism kinases such as AMPactivated protein kinase, genes, and nuclear factors like peroxisome proliferator-activated receptors, Liver X receptors, and peroxisome proliferator-activated receptor gamma coactivator 1-alpha in liver and skeletal muscle and affected adipocyte differentiation…”
BackgroundInfluentialEffects of Momordica charantia (Bitter Melon) on Ischemic Diabetic Myocardium
Czompa, A., Gyöngyösi, A., Szőke, K., Bak, I., Csépányi, E., Haines, D. D., Tósaki, Á., & Lekli, I. (2017) · Molecules · doi:10.3390/molecules22030488 · Cited by 23
“Investigations of therapeutic capacities of the plant have demonstrated that it can alter fat and carbohydrate metabolism in ways that mitigate T2DM symptoms [14].”
BackgroundChitosan based nanocarriers as a promising tool in treatment and management of inflammatory diseases
Goyal, S., Thirumal, D., Rana, J., Gupta, A. K., Kumar, A., Babu, M. A., Kumar, P., & Sindhu, R. K. (2024) · Carbohydrate Polymer Technologies and Applications · doi:10.1016/j.carpta.2024.100442 · Cited by 30
Effect of Bitter Melon Extracts on Lipid Levels in Japanese Subjects: A Randomized Controlled Study
Kinoshita, H., & Ogata, Y. (2018) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2018/4915784 · Cited by 26
“Several studies report that bitter melon (Momordica charantia) can improve blood glucose levels and lipid metabolism in animal models of dyslipidemia and diabetes [12, 13].”
BackgroundInfluentialPoovitha, S., & Parani, M. (2017) · Journal of Functional Foods · doi:10.1016/j.jff.2017.08.022 · Cited by 18
Lu, K., Chen, S., Lin, Y., Wu, H., & Chao, P. (2020) · Food Science & Nutrition · doi:10.1002/fsn3.1966 · Cited by 21
“…triterpenoids (saponins), present in seeds or fruits, with various mechanisms of action, including insulin-like effect, PPARγ activation (insulin sensitizer), α-glucosidase inhibitor, secretagogues, etc., have been proposed (Alam et al., 2015; Joseph & Jini, 2013; Oh, 2015; Wang et al., 2017).”
BackgroundYoshizaki, T., Ishihara, J., Kotemori, A., Yamamoto, J., Kokubo, Y., Saito, I., Yatsuya, H., Yamagishi, K., Sawada, N., Iwasaki, M., et al. (2019) · Journal of Epidemiology · doi:10.2188/jea.je20180130 · Cited by 20
Antidiabetic and hepato-renal protective effects of medicinal plants in STZ induced diabetic rats
Tehseen, I., Haq, T. U., Ilahi, I., Khan, A. A., Attaullah, M., Zamani, G. Y., Zaman, S., & Ismail, I. (2022) · Brazilian Journal of Biology · doi:10.1590/1519-6984.260189 · Cited by 18
Identification of a Triterpenoid as a Novel PPARγ Activator Derived from Formosan Plants
Weng, J., Bai, L., & Lin, W. (2017) · Phytotherapy Research · doi:10.1002/ptr.5900 · Cited by 26
“charantia is not only used as vegetables but also as used for alternative medicine in Asia for several centuries (Alam et al., 2015).”
BackgroundPhimarn, W., Sungthong, B., Saramunee, K., & Caichompoo, W. (2018) · Pharmacognosy Magazine · doi:10.4103/pm.pm_215_17 · Cited by 16
Xu, L., Xu, Y., Wang, S., Deng, Q., Wu, C., Chen, X.-T., & Wang, H. (2016) · Journal of Nutrition & Intermediary Metabolism · doi:10.1016/j.jnim.2016.04.002 · Cited by 15
AMPK activators for the prevention and treatment of neurodegenerative diseases
Neumann, N. R., Thompson, D. C., & Vasiliou, V. (2021) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2021.1991308 · Cited by 15
“It grows in multiple regions of the world and is a component of several traditional medicines [159,161,162].”
BackgroundLee, H. J., Cui, R., Choi, S., Jeon, J. Y., Kim, H. J., Kim, T. H., KANG, Y. Y., & Lee, K. W. (2018) · Food & Nutrition Research · doi:10.29219/fnr.v62.1319 · Cited by 12
“BME is also known for improving high fat diet (HFD)-induced obesity and hyperlipidemia in animal models (10, 11).”
BackgroundArafat, S. Y., Nayeem, M., Jahan, S., Karim, Z., Reza, H. M., Hossain, H., Shohel, M., & Alam, M. A. (2016) · Oriental Pharmacy and Experimental Medicine · doi:10.1007/s13596-016-0242-x · Cited by 12
“It has long been used for the treatment of diabetes, rheumatism, gout, fever and liver diseases (Alam et al. 2015; Ghani 2003).”
MethodSelf-citationChuang, L., Shih, Y.-H., Huang, W.-C., Lin, L.-C., Hsu, C., Chyuan, J., Tsai, T., & Tsai, P. (2020) · Molecules · doi:10.3390/molecules25184277 · Cited by 13
“WBM fruits and leaves are widely consumed on a daily basis, as well as used as folk remedies to treat numerous conditions and symptoms, including relieving metabolic syndromes [7], diabetes [8] and inflammatory responses [9], lowering blood lipid and glucose levels [10] and also for slowing the progression of certain…”
BackgroundNutraceuticals in the Management of Cardiovascular Risk Factors: Where is the Evidence?
Russell, C., Keshavamurthy, S., & Saha, S. P. (2021) · Cardiovascular & Haematological Disorders - Drug Targets · doi:10.2174/1871529x21666211201104124 · Cited by 16
Effect of Bitter Melon on Spatial Memory of Rats Receiving a High-Fat Diet
Sepehri, H., Hojati, A., & Safari, R. (2019) · Journal of Experimental Pharmacology · doi:10.2147/jep.s231260 · Cited by 15
“Similar results have been reported in other studies.(7,14,15) In this study, rats were trained for five days and behavior testing was carried out on day six.”
ResultParra, A. L., Menéndez, R., Ferrer, J. P., Hang, P. T. N., Phuong, N. T., Menéndez, A. B., Hernández, O. D. L., Guanaluce, D. C., Ferradá, C. R., Yaquis, A. S. P., et al. (2021) · Journal of Pharmacy & Pharmacognosy Research · doi:10.56499/jppres21.1018_9.4.537 · Cited by 13
“Its traditional use as medicine against various diseases dates back to ancient times (Roig y Mesa, 1974; Garau et al., 2003; Singh et al., 2011), been the fruits the most used portion of the plant, especially for diabetes treatments (Alam et al., 2015; Jia et al., 2017; Fan et al., 2019).”
BackgroundMethodInfluentialMedicinal Properties of Bitter Gourd: Bioactives and Their Actions
Aeri, V., & Raj, R. (2020) · Compendium of plant genomes · doi:10.1007/978-3-030-15062-4_3 · Cited by 14
Cardiovascular benefits of Momordica charantia in cholesterol-fed Wistar rats
Innih, S. O., Ikechi, E. G., & Omage, K. (2021) · Clinical Phytoscience · doi:10.1186/s40816-021-00303-2 · Cited by 11
“charantia juice was found to reduce adiposity and it was reported that extracts from this plant may reduce visceral obesity [20, 21].”
BackgroundReed, D., Kumar, D., Kumar, S., Raina, K., Punia, R., Kant, R., Saba, L. M., Cruickshank-Quinn, C. I., Tabakoff, B., Reisdorph, N. A., et al. (2021) · Journal of Traditional and Complementary Medicine · doi:10.1016/j.jtcme.2021.08.011 · Cited by 11
Anti-diabetic Effects of Ethanol Extract from Bitter Melon in Mice Fed a High-fat Diet
Yoon, N. A., Park, J., Lee, J., Jeong, J. Y., Kim, H.-K., Lee, H. S., Hwang, I. G., Roh, G. S., Kim, H. J., Cho, G. J., et al. (2017) · Development & Reproduction · doi:10.12717/dr.2017.21.3.259 · Cited by 11
“Previous studies have shown that in mice fed HFD, freeze-dried Momordica charantia juice was found to possess the potential to reduce adiposity, and extracts from this plant may reduce visceral obesity (Chen et al., 2003; Alam et al., 2015; Mahmoud et al., 2017).”
BackgroundInfluentialImprovement of testosterone deficiency by fermented Momordica charantia extracts in aging male rats
Lee, K.-S., Kim, H. P., Park, H., & Yoon, Y. (2021) · Food Science and Biotechnology · doi:10.1007/s10068-020-00872-x · Cited by 10
“Gong et al. (2017) and Wang and Ryu (2015) reported the effects of MEs on antiobesity activity and reduction in abdominal fat, while Alam et al. (2015) reported the effects of MC on weight decrease and metabolic syndrome relief, which are generally consistent with our findings in this study.”
ResultKandhari, K., Paudel, S., Raina, K., Agarwal, C., Kant, R., Wempe, M. F., O'Bryant, C., & Agarwal, R. (2021) · Journal of Cancer Prevention · doi:10.15430/jcp.2021.26.4.266 · Cited by 10
“Additionally, both cultivars of bitter melon showed a comparable good safety profile ( no toxic effect on non-target organs), which is in concurrence with previously published data in human subjects [27-29].”
Exploiting Gynoecious Line for Earliness and Yield Traits in Bitter Gourd (Momoredica charantia L.)
Alhariri, A., Behera, T. K., Munshi, A. D., et al. (2018) · International Journal of Current Microbiology and Applied Sciences · doi:10.20546/ijcmas.2018.711.108 · Cited by 9
“Fruits and seeds of bitter gourdare not only used for its hypoglycemic properties, but also against cancer, malaria, ulcer, dyslipidemia, and hypertension (Alam et al., 2015) with its anti-inflammatory, antiviral, and antibacterial properties (Budrat et al.”
BackgroundWu, S., Huang, C., Chen, Y.-R., Huang, H., Huang, W., & Lai, Y. (2021) · Journal of Functional Foods · doi:10.1016/j.jff.2021.104857 · Cited by 11
Qin, C., Wang, J., Zhao, W., Pi, D., Yan, X., & Nie, G. (2022) · Aquaculture Nutrition · doi:10.1155/2022/3705943 · Cited by 9
“Studies in mice have shown that BME ameliorated obesity induced by high-fat diets [27].”
BackgroundNutritional Approaches to Enhance GLP-1 Analogue Therapy in Obesity: A Narrative Review
Dias, D. D., Vasconcelos, A. R., Souza, A. C. R., Menezes, C. D., Silva, I. S. T. E., & Name, J. J. (2025) · Obesities · doi:10.3390/obesities5040088 · Cited by 8
“Bitter melon ( Momordica charantia ) Clinical (RCTs and meta-analyses), preclinical ↑ GLP-1 and insulin; ↓ fasting glucose, HbA1c, TC, TG, LDL, and weight [193–201].”
Bitter Gourd for Human Health, Nutrition, and Value Addition
Jat, G. S., Behera, T. K., & Reddy, U. K. (2023) · Springer eBooks · doi:10.1007/978-981-19-9016-8_8 · Cited by 10
Phenolic Profile and Biological Properties of Momordica charantia
Khalid, Z., Hassan, S. M., Mughal, S. S., et al. (2021) · Chemical and Biomolecular Engineering · doi:10.11648/j.cbe.20210601.13 · Cited by 8
“Bitter gourd has been used as folk medicine to cure toothache, diarrhea, furuncle, diabetes, dysmenorrhea, eczema, emmenagogue, galactagogue, gout, jaundice, kidney (stone), leprosy, leucorrhea, piles, pneumonia, psoriasis, rheumatism and scabies [3].”
BackgroundAntidiabetic Property of Aloe vera (Aloe barbadensis) and Bitter Melon (Momordica charantia)
Malik, J. A., Iqbal, S., Biswas, J., Riaz, U., & Datta, S. (2021) · Springer eBooks · doi:10.1007/978-3-030-58975-2_10 · Cited by 12
Cheong, N. D. H., Zakaria, L. A., & Yusof, H. (2022) · Malaysian Journal of Medicine and Health Sciences · doi:10.47836/mjmhs.18.s15.21 · Cited by 12
Effect of Momordica charantia, Camellia sinensis and Cinnamon Species on Insulin Resistance
Hebi, M. (2014) · Medicinal & Aromatic Plants · doi:10.4172/2167-0412.1000182 · Cited by 7
“Bitter melon induced a significant increase in levels of adiponectin and the expression of PPARγ, perhaps mediated by this increase, the reversal of the entire deleterious metabolic indices [92].”
BackgroundXu, Y., Xu, L., Chen, X.-T., Sun, P., Qing-yan, G. U. O., & Wang, H. (2016) · Journal of Nutrition & Intermediary Metabolism · doi:10.1016/j.jnim.2016.04.003 · Cited by 7
Bitter Melon: A Multifunctional Medicinal Plant with Powerful Bioactive Compounds
Pehlivan, F. E. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.98812 · Cited by 10
“Bitter melon dietary supplementation has been widely studied to treat several diseases, such as obesity and cancer, promising to possess hypoglycemic and lipidlowering properties [17].”
BackgroundNutraceuticals in Glucose Balance and Diabetes
Garg, R. C. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802147-7.00012-7 · Cited by 9
Muthupandi, K., Marwal, A., & Tennyson, J. (2019) · 3 Biotech · doi:10.1007/s13205-019-1775-8 · Cited by 7
Bai, J., Zhu, Y. G., & Dong, Y. (2018) · Genes & Genomics · doi:10.1007/s13258-017-0642-4 · Cited by 7
Malik, R. A., Saad, M. M., & Tiwari, S. (2019) · Asian Journal of Chemistry · doi:10.14233/ajchem.2019.21715 · Cited by 10
Kučerová, J., Kotolová, H., & Koupý, D. (2015) · Česká a slovenská farmacie · doi:10.36290/csf.2015.028 · Cited by 6
Amini, M. R., Rasaei, N., Jalalzadeh, M., Pourreza, S., & Hekmatdoost, A. (2024) · Phytotherapy Research · doi:10.1002/ptr.8357 · Cited by 5
“…(LXRs), peroxisome proliferator-activated recep- tor-γ coactivator (PGC)- 1α, and fatty acid-binding protein 1 increase, and these mechanisms ultimately cause adiposity reduction and dyslipidemia improvement (Alam et Huang et al. 2008; Kinoshita and Ogata 2018; Kumari, Dash, and Behera 2018).”
Zöld, E. L., Toth, L. M., Farczádi, L., & Ștefănescu, R. (2023) · Natural Product Research · doi:10.1080/14786419.2023.2213805 · Cited by 11
“…the pharmacological effects of bitter melon are the cucurbitane-type triterpenoids (Harinantenaina et al. 2006; Wang et al. 2012; Zeng et al. 2014; alam et al. 2015; Jia et al. 2017; Venkatakrishnan et al. 2019), phenolics (Horax et al. 2006), poly-peptides (Choudhary et al. 2012), carotenoids…”
BackgroundOgwu, M. C., Ogwu, H. I., & Kosoe, E. A. (2023) · Reference series in phytochemistry · doi:10.1007/978-3-031-21973-3_4-1 · Cited by 9
Houacine, C., Singh, J., Singh, R., et al. (2021) · The Gazette of Medical Sciences · doi:10.46766/thegms.pharma.21062806 · Cited by 5
“Momordica charantia (MC) or bitter melon is a well-known plant which has been used for thousands of years as a natural medicine to treat several diseases including diabetes and cancer inflicting mankind [15, 33].”
BackgroundSaad, B., Zaid, H., Shanak, S., & Kadan, S. (2017) · Springer eBooks · doi:10.1007/978-3-319-54102-0_6 · Cited by 8
Bijalwan, P., Yadav, A., Sharma, M., Kaushik, P., Kumar, P., Chandola, J. C., Ravat, P., Yadav, V., Mishra, D. S., Tunç, Y., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-08862-x · Cited by 4
Advancements in the Esterification of Phytosterols Catalyzed by Immobilized Lipase
Zhang, Y., Yan, Y., Lin, Z., et al. (2025) · Catalysts · doi:10.3390/catal15030225 · Cited by 4
Ștefan, C. S. (2022) · FARMACIA · doi:10.31925/farmacia.2022.1.21 · Cited by 4
“contains certain phytocompounds with a significant hypoglycaemic role, such as: charantin, momordicin, momordenol, zeatin, zeinoxanthin amino acids, Ppolypeptides sometimes being referred to as insulin plant [27, 28].”
BackgroundJaichand, V., Mellem, J. J., & Mohanlall, V. (2024) · Food Science and Technology · doi:10.5327/fst.00177 · Cited by 6
Momordica charantia no tratamento do diabetes mellitus e nefropatia diabética
Nunes, L. D. O., Rauber, L. N., Góis, M. T., et al. (2023) · Scientific Electronic Archives · doi:10.36560/16320231681 · Cited by 4
The Gazette of Medical Sciences
Houacine, C., Singh, J., Singh, R., et al. (2020) · The Gazette of Medical Sciences · doi:10.46766/thegms · Cited by 4
Kundu, B. C., Mohsin, G. M., Rahman, M. S., et al. (2022) · Brazilian Journal of Biology · doi:10.1590/1519-6984.255605 · Cited by 3
Self-citationSagor, M. A. T., Reza, H. M., Tabassum, N., et al. (2018) · Dhaka University Journal of Pharmaceutical Sciences · doi:10.3329/dujps.v16i2.35258 · Cited by 3
“The previous study also explored that bitter melon regulates peroxisome proliferatoractivated receptors (PPARs), monocyte chemoattractant protein-1 (MCP-1) and fatty acid synthesis (FAS) related genes.(16) Bitter melon also reduced inflammatory, pro-inflammatory, fibrogenic, profibrogenic and iron-mediated protein.”
BackgroundInfluentialSelf-citationWang, C.-L., Kung, H., Wu, C., & Huang, C. (2018) · Food & Function · doi:10.1039/c8fo01777h · Cited by 3
Sivagnanapazham, K., KARTHIKEYAN, G., Boopathi, N. M., et al. (2025) · 3 Biotech · doi:10.1007/s13205-025-04484-2 · Cited by 2
“Traditionally, bitter gourd is used in herbal medicine, which recognized for its anti-helminthic, anti-diabetic, antiviral, anti-malarial, anti-cancer, and nutritional properties (Alam et al. 2015).”
Hanoman, C., Singh, J., Rupee, K., Rupee, S., Ansari, A. A., Cummings, E., & Behl, S. (2021) · Advances in biochemistry in health and disease · doi:10.1007/978-3-030-84763-0_21 · Cited by 3
Diversity of begomoviruses associated with gourds
Shankarappa, K. S., Venkataravanappa, V., Mohanraj, M., et al. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90587-9.00002-x · Cited by 2
Allo-polyherbal Approaches for Managing Metabolic Syndrome: A Narrative Review
Sharma, P., Singh, V., & Baldi, A. (2023) · The Natural Products Journal · doi:10.2174/0122103155272968231003030032 · Cited by 4
Nutraceuticals for diabetes and glucose balance
Gupta, R. C., Doss, R. B., Garg, R. C., Lall, R., Srivastava, A., & Sinha, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821038-3.00006-9 · Cited by 5
Mohammadmoradi, S., Howatt, D. A., Lu, H. S., Daugherty, A., & Saha, S. P. (2020) · Current Developments in Nutrition · doi:10.1093/cdn/nzaa148 · Cited by 2
“charantia), colloquially known as bitter melon, is a product that has been used traditionally for treatment of diabetes (4).”
Alnoman, M. M. (2023) · Annals of Phytomedicine An International Journal · doi:10.54085/ap.2023.12.2.68 · Cited by 1
Wendt, J. A., Considine, C., & Kogan, M. (2021) · Springer eBooks · doi:10.1007/978-3-030-81758-9_5 · Cited by 3
Mohanty, S., & Pattnaik, A. K. (2025) · Chemistry & Biodiversity · doi:10.1002/cbdv.202401532 · Cited by 2
“In addition, an adipogenesis differentiation assay was performed on the 3T3-L1 cell line [25, 26].”
Ajibare, A. J., Akintoye, O. O., Oriowo, O. A., Ayoola, A. M., Oriyomi, I. A., Adedara, J. F., Oluwamoroti, F. O., Olaniyi, K. S., & Salami, K. T. (2025) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-025-00845-z · Cited by 1
Jan, B., Rizvi, Q. U. E. H., Shams, R., Dar, A. H., Singh, A. K., & Khan, S. A. (2020) · Springer eBooks · doi:10.1007/978-981-15-7470-2_9 · Cited by 3
Alternative Approach of Nutraceuticals in Management of Diabetes Mellitus
Kumar, V., Bajaj, R., Shekhawat, M., Rani, A., & Singh, G. (2022) · Current Nutrition & Food Science · doi:10.2174/1573401319666221124162331 · Cited by 2
Mansouridara, M., GhasemGheshlagi, N. R., Heydari, F., Ghazalian, F., Ebrahimi, S., Askari, R., & Rashedi, F. (2022) · مجله علمی پزشکی جندی شاپور · doi:10.32598/jsmj.21.4.2515 · Cited by 1
Ogwu, M. C., Ogwu, H. I., & Kosoe, E. A. (2024) · Reference series in phytochemistry · doi:10.1007/978-3-031-43199-9_4 · Cited by 1
Ramadhani, F., Badu, F. D., Djafar, L., Hanapi, S., & Pahrun, D. T. (2021) · Kinestetik Jurnal Ilmiah Pendidikan Jasmani · doi:10.33369/jk.v5i2.14825 · Cited by 1
“This increase in body fat can change the risk of several diseases such as diabetes, hyperlipidemia, and hypertension, which are cardiovascular diseases and metabolic syndromes (Alam et al., 2015).”
BackgroundTsabang, N. (2021) · Diabetes & Obesity International Journal · doi:10.23880/doij-16000247
Formulation of Chitosan-Saponin Microbeads using Microfluidic Technology
Yong, J., Koh, K. S., Wong, V.-L., et al. (2022) · IOP Conference Series Materials Science and Engineering · doi:10.1088/1757-899x/1257/1/012030 · Cited by 1
Metadata
- Authors
- Alam, M. A., Uddin, R., Subhan, N., Rahman, M. M., Jain, P., & Reza, H. M.
- Affiliations
- North South University (BD)
- Stamford University Bangladesh (BD)
- Charles Sturt University (AU)
- Department of Pharmaceutical Sciences, North South University, Dhaka 1229, Bangladesh
- Corresponding author
- Alam, Md Ashraful
- Reza, Hasan Mahmud
- Venue
- Journal of Lipids
- Publisher
- Wiley
- Published
- 2015
- Volume
- 2015
- Pages
- 1-18
- ISSN
- 2090-3030 (ISSN-L)
- 2090-3049
- PMC
- PMC4306384
- OpenAlex
- W2002317151
- Semantic Scholar
- 7e58fcc6d7df4d25c8ba35d06f651567d26d5d5d
- Cited by
- 123
- References
- 153
- Citations by year
- 2026: 4 · 2025: 11 · 2024: 10 · 2023: 7 · 2022: 13 · 2021: 24 · 2020: 10 · 2019: 12 · 2018: 15 · 2017: 9 · 2016: 5 · 2015: 2
- FWCI
- 1.55
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Journal of Lipids (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Greater South Information System
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Natural Antidiabetic Agents Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Advances in Cucurbitaceae Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- Momordica charantia, obesity, metabolic syndrome, diabetes mellitus, hypoglycemic activity, antioxidant activity, AMPK, peroxisome proliferator-activated receptors, lipid metabolism, fat metabolism, plant extracts, complementary and alternative medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.